Role of Asymmetric Dimethylarginine and Nitric Oxidein Type 2 Diabetes Mellitus and its Cardiovascular Complications - Egyptian Knowledge Bank - troweb

54710

Role of Asymmetric Dimethylarginine and Nitric Oxidein Type 2 Diabetes Mellitus and its Cardiovascular Complications

Article

Last updated: 01 Jan 2025

Overview Similar Items

Article

Role of dipeptidyl peptidase 4 in type 2 diabe tes mellitus

Article

RELATIONSHIP BETWEEN ASYMMETRIC DIMETHYLARGININE (ADMA) AND ATHEROSCLEROSIS IN CHRONIC RENAL FAILURE PATIENTS

Article

MALONDIALDEHYDE IN TYPE 2 DIABETICS AND ASSOCIATION WITH CARDIOVASCULAR RISK FACTORS

Article

Type 2 Diabetes Mellitus and Role of Adiponectin in Insulin Resistance

Article

Role of aldose reductase and arginase inhibitors in diabetic vascular and behavioral complications.

Article

The Emerging Role of 8- Isoprostane and ADMA in the Diagnosis of Diabetic Nephropathy

Article

A putative role for oxidative stress in pathophysiology of diabetic cardiomyopathy

Article

PLASMA LEVELS OF ASYMMETRIC DI METHYL ARGININE IN DIABETIC PATIENTS WITH NEUROPATHIC FOOT ULCERATION

Article

Prognostic Value of Asymmetric Dimethylarginine in Patients with Acute Coronary Syndrome

Article

Lipoprotein (A) In Type 2 Diabetes Mellitus as A Marker of Atherosclerotic Cardiovascular Disease